Literature DB >> 10596681

A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients.

A Chaouat1, E Weitzenblum, R Kessler, C Charpentier, M Enrhart, R Schott, P Levi-Valensi, J Zielinski, L Delaunois, R Cornudella, J Moutinho dos Santos.   

Abstract

The beneficial effects of nocturnal oxygen therapy (NOT) in chronic obstructive pulmonary disease (COPD) patients with mild-to-moderate daytime hypoxaemia (arterial oxygen tension (Pa,O2) in the range 7.4-9.2 kPa (56-69 mmHg)) and exhibiting sleep-related oxygen desaturation remains controversial. The effectiveness of NOT in that category of COPD patients was studied. The end points included pulmonary haemodynamic effects after 2 yrs of follow-up, survival and requirement for long-term oxygen therapy (LTOT). Seventy-six patients could be randomized, 41 were allocated to NOT and 35 to no NOT (control). The goal of NOT was to achieve an arterial oxygen saturation of >90% throughout the night. All these patients underwent polysomnography to exclude an associated obstructive sleep apnoea syndrome. The two groups exhibited an identical meansD daytime Pa,O2 of 8.4+/-0.4 kPa (63+/-3 mmHg) at baseline. Twenty-two patients (12 in the NOT group and 10 in the control group, p=0.98) required LTOT during the whole follow-up (35+/-14 months). Sixteen patients died, nine in the NOT group and seven in the control group (p=0.84). Forty-six patients were able to undergo pulmonary haemodynamic re-evaluation after 2 yrs, 24 in the NOT and 22 in the control group. In the control group, mean resting pulmonary artery pressure increased from 19.8+/-5.6 to 20.5+6.5 mmHg, which was not different from the change in mean pulmonary artery pressure in the NOT group, from 18.3+/-4.7 to 19.5+/-5.3 mmHg (p= 0.79). Nocturnal oxygen therapy did not modify the evolution of pulmonary haemodynamics and did not allow delay in the prescription of long-term oxygen therapy. No effect of NOT on survival was observed, but the small number of deaths precluded any firm conclusion. These results suggest that the prescription of nocturnal oxygen therapy in isolation is probably not justified in chronic obstructive pulmonary disease patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10596681     DOI: 10.1183/09031936.99.14510029

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  45 in total

1.  Burn injury associated with home oxygen use in patients with chronic obstructive pulmonary disease.

Authors:  Gulshan Sharma; Ragai Meena; James S Goodwin; Wei Zhang; Yong-Fang Kuo; Alexander G Duarte
Journal:  Mayo Clin Proc       Date:  2015-04       Impact factor: 7.616

Review 2.  Sleep-disordered breathing and COPD: the overlap syndrome.

Authors:  Robert L Owens; Atul Malhotra
Journal:  Respir Care       Date:  2010-10       Impact factor: 2.258

3.  Variations in physician interpretation of overnight pulse oximetry monitoring.

Authors:  Rory Ramsey; Reena Mehra; Kingman P Strohl
Journal:  Chest       Date:  2007-07-23       Impact factor: 9.410

4.  The Long-Term Oxygen Treatment Trial for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned.

Authors:  Roger D Yusen; Gerard J Criner; Alice L Sternberg; David H Au; Anne L Fuhlbrigge; Richard K Albert; Richard Casaburi; James K Stoller; Kathleen F Harrington; J Allen D Cooper; Philip Diaz; Steven Gay; Richard Kanner; Neil MacIntyre; Fernando J Martinez; Steven Piantadosi; Frank Sciurba; David Shade; Thomas Stibolt; James Tonascia; Robert Wise; William C Bailey
Journal:  Ann Am Thorac Soc       Date:  2018-01

Review 5.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 6.  Sleep abnormalities and treatment in emphysema.

Authors:  Samuel Krachman; Omar A Minai; Steven M Scharf
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

7.  Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Minseok Seo; Weiliang Qiu; William Bailey; Gerard J Criner; Mark T Dransfield; Anne L Fuhlbrigge; John J Reilly; Mary Beth Scholand; Peter Castaldi; Robert Chase; Margaret Parker; Aabida Saferali; Jeong H Yun; James D Crapo; Michael H Cho; Terri H Beaty; Edwin K Silverman; Craig P Hersh
Journal:  J Mol Med (Berl)       Date:  2018-10-23       Impact factor: 4.599

Review 8.  Respiratory disorders during sleep in chronic obstructive pulmonary disease.

Authors:  Oreste Marrone; Adriana Salvaggio; Giuseppe Insalaco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 9.  Changing the burden of COPD mortality.

Authors:  David M Mannino; Victor A Kiriz
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Treatment of respiratory failure in COPD.

Authors:  Stephan Budweiser; Rudolf A Jörres; Michael Pfeifer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.